Skip to main content

Table 2 Confirmation of 0.75 mg/kgbody weight as the dose of advantus™ chewable tablet

From: Development of advantus™(imidacloprid) soft chewable tablets for the treatment of Ctenocephalides felis infestations on dogs

Time1

Treatment

Variable

N

Mean

Std Dev

Minimum

Maximum

Efficacy (%)

p-value

8

IVP2

Count

8

3.00

6.55

0.00

19.00

  

LogCount

8

0.31

0.46

0.00

1.30

98.63

<.00014

CVP3

Count

8

85.13

27.37

18.00

100.00

LogCount

8

1.89

0.25

1.28

2.00

12

IVP

Count

8

0.13

0.35

0.00

1.00

99.90

<.00014

LogCount

8

0.04

0.11

0.00

0.30

CVP

Count

8

89.75

7.32

78.00

98.00

LogCount

8

1.96

0.04

1.90

2.00

24

IVP

Count

8

0.00

0.00

0.00

0.00

100.00

<.00014

LogCount

8

0.00

0.00

0.00

0.00

CVP

Count

8

91.13

6.62

82.00

100.00

LogCount

8

1.96

0.03

1.92

2.00

  1. 1Time in hours post-treatment when efficacy was determined
  2. 2IVP is the advantus™ chewable tablets as the investigational veterinary product
  3. 3CVP is the placebo chewable tablets as control veterinary product
  4. 4Statistically significant at p < 0.01